TERN
HEALTHCARETerns Pharmaceuticals Inc
$52.95-0.02 (-0.04%)PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving TERN Today?
No stock-specific AI insight has been generated for TERN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.49$53.19
$52.95
Fundamentals
Market Cap$6.1B
P/E Ratio—
EPS$-1.03
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding115.5M
TERN News
27 articles- MSD concludes Terns acquisition to expand CML pipelineHospitalmanagement·May 6, 2026
- Merck Completes Acquisition of Terns Pharmaceuticals, Inc.Yahoo Finance·May 5, 2026
- Merck still sees ‘compelling’ outlook for Terns leukemia drugBiopharmadive·Apr 30, 2026
- Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid LeukemiaYahoo Finance·Apr 27, 2026
- Merck Advances Terns Deal And Cardiovascular And RSV Growth OptionsYahoo Finance·Apr 26, 2026
- Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.Yahoo Finance·Apr 24, 2026
- UBS Raises Merck (MRK) Price Forecast as Part of Sector PreviewYahoo Finance·Apr 17, 2026
- AZN vs. MRK: Which Oncology Stock Offers Better Investment Potential?Yahoo Finance·Apr 9, 2026
- Why Terns Pharmaceuticals Stock Rocked the Market in MarchMotley Fool·Apr 8, 2026
- Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data ReviewBenzinga·Apr 7, 2026
- What's Going On With Merck Stock Tuesday?Benzinga·Apr 7, 2026
- Merck’s Terns Deal Targets Cancer Pipeline And Keytruda Patent RisksYahoo Finance·Apr 7, 2026
- Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.Yahoo Finance·Apr 7, 2026
- Terns rebuffed a higher bid before selling to MerckBiopharmadive·Apr 7, 2026
- Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and MizuhoYahoo Finance·Apr 6, 2026
- Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)Yahoo Finance·Apr 2, 2026
- Merck Just Made a Big Bet on a New Cancer Growth EngineInvesting.com·Apr 2, 2026
- Assessing Terns Pharmaceuticals (TERN) Valuation After Strong Recent Share Price MomentumYahoo Finance·Apr 2, 2026
- Merck (MRK) Reports Strong Phase 3 Results for Oral PCSK9Yahoo Finance·Apr 2, 2026
- Merck Locks Infinimmune Alliance To Chase Next-Gen Antibody DrugsBenzinga·Apr 1, 2026
- Biotechs Are a Healthy Growth Bet. Thank M&A and New Drugs.Yahoo Finance·Mar 31, 2026
- Western Digital upgraded, PayPal initiated: Wall Street's top analyst callsYahoo Finance·Mar 31, 2026
- Here Are Tuesday’s Top Wall Street Analyst Research Calls: Arista Networks, Block, Colgate-Palmolive, Digital Realty, Emerson Electric, MiniMed, Shake Shack, and More247 Wall St·Mar 31, 2026
- Merck’s strategic shift: acquires Terns for $6.7bn, targeting dominance in CMLPharmaceutical-technology·Mar 30, 2026
- Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: AnalystBenzinga·Mar 25, 2026
- Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)Benzinga·Mar 25, 2026
- Merck Nears $6 Billion Deal To Buy Terns Pharma: ReportBenzinga·Mar 25, 2026
All 27 articles loaded
Price Data
Open$52.96
Previous Close$52.95
Day High$52.96
Day Low$52.93
52 Week High$53.19
52 Week Low$0.49
52-Week Range
$0.49$53.19
$52.95
Fundamentals
Market Cap$6.1B
P/E Ratio—
EPS$-1.03
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding115.5M
About Terns Pharmaceuticals Inc
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of nonalcoholic steatohepatitis (NASH) and other chronic liver diseases. The company is headquartered in Foster City, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—